文献速递免疫规划传染病防控与疫情报告

五类低资源地区儿童腹泻疫苗对抗生素使用的影响:一项比较模拟研究

The impact of vaccines for diarrhoea on antibiotic use among children in five low-resource settings: a comparative simulation study.
PubMed 文献 · Lancet Glob Health · 2024-01-01

该研究基于2009至2012年孟加拉国、印度、尼泊尔、巴基斯坦和坦桑尼亚出生队列中1119名儿童的数据,采用蒙特卡洛模拟评估九种疫苗接种情景对腹泻抗生素治疗、总体抗生素疗程及旁观病原体抗生素暴露的影响。模拟结果显示,志贺菌疫苗在单一疫苗中减少幅度最大,腺病毒-诺如病毒-轮状病毒联合疫苗在联合疫苗中减少幅度最大;但2021年预测效应较2009至2012年估计值缩小45%至74%。作者认为肠道病原体疫苗每年每100名接种儿童最多可预防8至12个抗生素疗程,类似低资源地区儿童总体抗生素使用减少超过1%可能需要联合疫苗。

要点

  • 志贺菌疫苗在单一疫苗中减少全部病因腹泻抗生素疗程、总体抗生素疗程及旁观病原体抗生素暴露的幅度最大。
  • 腺病毒-诺如病毒-轮状病毒联合疫苗在联合疫苗中减少抗生素使用的幅度最大。
  • 2021年预测的疫苗对 antibiotics 使用的影响较2009至2012年估计值缩小45%至74%。

核心结论

  • 肠道病原体疫苗每年每100名接种儿童最多可预防8至12个抗生素疗程。
  • 类似低资源地区儿童总体抗生素使用减少超过1%可能需要联合疫苗。

研究设计与样本

  • 研究分析了2009至2012年在孟加拉国、印度、尼泊尔、巴基斯坦和坦桑尼亚入组的纵向出生队列儿童数据。
  • 采用蒙特卡洛模拟估算九种疫苗接种情景(包括六种单一疫苗和三种联合疫苗)对腹泻抗生素治疗、总体抗生素疗程及旁观病原体抗生素暴露的假设影响。

主要发现

  • 在1119名儿童中,共有3029例抗生素治疗的腹泻发作(每100儿童年135.3个疗程)。
  • 与其他单一病原体疫苗相比,志贺菌疫苗对全部病因腹泻抗生素疗程的相对减少为6.1%,绝对减少为每100儿童年8.2个疗程(95%CI -9.4至-7.2)。
  • 志贺菌疫苗对总体抗生素疗程的相对减少为1.0%,绝对减少为每100儿童年8.2个疗程(95%CI -9.4至-7.2)。
  • 志贺菌疫苗对旁观病原体抗生素暴露的相对减少为1.2%,绝对减少为每100儿童年15.9个疗程(95%CI -18.5至-13.8)。
  • 与其他联合疫苗相比,腺病毒-诺如病毒-轮状病毒疫苗减少抗生素使用的幅度最大,为每100儿童年12.2个疗程(95%CI -13.7至-11.0)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vaccines for diarrhoea could have the ancillary benefit of preventing antibiotic use. We aimed to quantify and compare the expected impact of enteric vaccines on antibiotic use via Monte Carlo simulations. METHODS: We analysed data from a longitudinal birth cohort, which enrolled children from 2009 to 2012 from Bangladesh, India, Nepal, Pakistan, and Tanzania. We used Monte Carlo simulations to estimate hypothetical vaccine impact in nine vaccination scenarios (including six single vaccines and three combination vaccines) on antibiotic- treated diarrhoea, overall antibiotic courses, and antibiotic exposures to bystander pathogens. For each vaccine scenario, we randomly selected target pathogen-specific diarrhoea episodes to be prevented according to the specified vaccine efficacy and estimated the absolute and relative differences in incidence of antibiotic use outcomes between vaccine and no vaccine scenarios. FINDINGS: Among 1119 children, there were 3029 (135·3 courses per 100 child-years) antibiotic-treated diarrhoea episodes. Based on simulated results, a Shigella vaccine would cause the greatest reductions compared with the other single pathogen vaccines in antibiotic courses for all-cause diarrhoea (6·1% relative reduction; -8·2 courses per 100 child-years [95% CI -9·4 to -7·2]), antibiotic courses overall (1·0% relative reduction; -8·2 courses per 100 child-years [-9·4 to -7·2]), and antibiotic exposures to bystander pathogens (1·2% relative reduction; -15·9 courses per 100 child-years [-18·5 to -13·8]). An adenovirus-norovirus-rotavirus vaccine would cause the greatest reductions in antibiotic use (12·2 courses per 100 child-years [-13·7 to -11·0]) compared with the other combination vaccines. However, projected vaccine effects on antibiotic use in 2021 were 45-74% smaller than those estimated in 2009-12 accounting for reductions in diarrhoea incidence in the past decade. INTERPRETATION: Vaccines for enteric pathogens could result in up to 8-12 prevented courses of antibiotics per 100 vaccinated children per year. Combination vaccines will probably be necessary to achieve greater than 1% reductions in total antibiotic use among children in similar low-resource settings. FUNDING: Wellcome Trust and Bill & Melinda Gates Foundation.

来源:Lancet Glob Health,查看原文。版权归原作者所有。

引用

  1. Rogawski McQuade ET, Brennhofer SA, Elwood SE, et al. The impact of vaccines for diarrhoea on antibiotic use among children in five low-resource settings: a comparative simulation study. Lancet Glob Health. 2024. PMID: 39577969. doi:10.1016/S2214-109X(24)00378-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。